EGFR family: Structure physiology signalling and therapeutic targets

被引:218
作者
Burgess, Antony W. [1 ]
机构
[1] Ludwig Inst Canc Res, Melbourne, Vic 3050, Australia
关键词
D O I
10.1080/08977190802312844
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
There are four members of the EGFR family: EGFR, erbB2, erbB3 and erbB4. These receptors form ligand-activated oligomers which regulate intracellular processes via an oligomeric tyrosine kinase scaffold. The receptors are activated when the extracellular domain undergoes a conformational change which facilitates either homo- or hetero-oligomerization with other family members. The absence of one EGFR family member leads to embryonic or early post-natal death due to implantation, central nervous system or cardiac defects. Many mouse models of defective or deficient EGFR family members are available for studying physiology and/or pathology of EGFR family members. Sophisticated antibody and kinase inhibitors which target different family members have been designed, produced. EGFR and erbB2 are frequently activated, over expressed or mutated in many common cancers and the antagonists and/or inhibitors of EGFR and/or erbB2 signalling have already been shown to have therapeutic benefits for cancer patients.
引用
收藏
页码:263 / 274
页数:12
相关论文
共 154 条
  • [61] Distinct domains in the SHP-2 phosphatase differentially regulate epidermal growth factor receptor/NF-κB activation through Gab1 in glioblastoma cells
    Kapoor, GS
    Zhan, Y
    Johnson, GR
    O'Rourke, DM
    [J]. MOLECULAR AND CELLULAR BIOLOGY, 2004, 24 (02) : 823 - 836
  • [62] Breast cancer: The upgraded role of HER-3 and HER-4
    Karamouzis, Michalis V.
    Badra, Filitsa A.
    Papavassiliou, Athanasios G.
    [J]. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2007, 39 (05) : 851 - 856
  • [63] Targeting TACE-dependent EGFR ligand shedding in breast cancer
    Kenny, Paraic A.
    Bissell, Mina J.
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2007, 117 (02) : 337 - 345
  • [64] EGF receptor is involved in WNT3a-mediated proliferation and motility of NIH3T3 cells via ERK pathway activation
    Kim, Sung-Eun
    Choi, Kang-Yell
    [J]. CELLULAR SIGNALLING, 2007, 19 (07) : 1554 - 1564
  • [65] Phase I trial of erlotinib with radiation therapy in patients with glioblastoma multiforme: Results of north central cancer treatment group protocol N0177
    Krishnan, Sunil
    Brown, Paul D.
    Ballman, Karla V.
    Fiveash, John B.
    Uhm, Joon H.
    Giannini, Caterina
    Jaeckle, Kurt A.
    Geoffroy, Francois J.
    Nabors, L. Burt
    Buckner, Jan C.
    [J]. INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 65 (04): : 1192 - 1199
  • [66] Expression of ErbB receptors during pancreatic islet development and regrowth
    Kritzik, MR
    Krahl, T
    Good, A
    Gu, D
    Lai, C
    Fox, H
    Sarvetnick, N
    [J]. JOURNAL OF ENDOCRINOLOGY, 2000, 165 (01) : 67 - 77
  • [67] Lassman AB, 2006, NEW ENGL J MED, V354, P525
  • [68] TNF-α induces MMP-9 expression via activation of Src/EGFR, PDGFR/PI3K/Akt cascade and promotion of NF-κB/p300 binding in human tracheal smooth muscle cells
    Lee, Chiang-Wen
    Lin, Chih-Chung
    Lin, Wei-Ning
    Liang, Kao-Chih
    Luo, Shue-Feng
    Wu, Chow-Bin
    Wang, Shyi-Wu
    Yang, Chuen-Mao
    [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 2007, 292 (03) : L799 - L812
  • [69] CLONING AND SEQUENCE-ANALYSIS OF A CDNA FOR RAT TRANSFORMING GROWTH FACTOR-ALPHA
    LEE, DC
    ROSE, TM
    WEBB, NR
    TODARO, GJ
    [J]. NATURE, 1985, 313 (6002) : 489 - 491
  • [70] REQUIREMENT FOR NEUREGULIN RECEPTOR ERBB2 IN NEURAL AND CARDIAC DEVELOPMENT
    LEE, KF
    SIMON, H
    CHEN, H
    BATES, B
    HUNG, MC
    HAUSER, C
    [J]. NATURE, 1995, 378 (6555) : 394 - 398